Cargando…
Intervention Thresholds for Treatment in Patients with Glucocorticoid-Induced Osteoporosis: Systematic Review of Guidelines
BACKGROUND: In this study, we aimed to evaluate and compare the treatment indication for patients with glucocorticoid-induced osteoporosis (GIOP) in various clinical practice guidelines. METHODS: We searched for potentially relevant studies conducted from January 2000 to March 2020 using online data...
Autores principales: | Lee, Tae-Han, Song, Yeo-Jin, Kim, Hyoungyoung, Sung, Yoon-Kyoung, Cho, Soo-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Bone and Mineral Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746480/ https://www.ncbi.nlm.nih.gov/pubmed/33317228 http://dx.doi.org/10.11005/jbm.2020.27.4.247 |
Ejemplares similares
-
Update on Glucocorticoid Induced Osteoporosis
por: Cho, Soo-Kyung, et al.
Publicado: (2021) -
Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
por: Park, So Young, et al.
Publicado: (2018) -
Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients
por: Cho, Soo-Kyung, et al.
Publicado: (2021) -
Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
por: Lee, Joo-Hyun, et al.
Publicado: (2014) -
Uptake of Biosimilars and Its Economic Implication for the Treatment of Patients with Rheumatoid Arthritis in Korea
por: Cho, Soo-Kyung, et al.
Publicado: (2021)